Made with ❤️ by True Sparrow

Bringing you the latest funding data

Pathios Therapeutics

Last funding round

Raised
$25,000,000
Round
Series B

Funding News (1)

Apr 18 2024PR Newswire

Startup details

Pathios Therapeutics

Pathios Therapeutics

Pathios Therapeutics is a biotech company focused on developing small molecule inhibitors of the pH-sensing G protein-coupled receptor GPR65 to counteract the GPR65 mediated immunosuppressive polarization of immune cells, including tumor associated macrophages, triggered by an acidic tumor microenvironment present in most cancers.
pathiostherapeutics.com
Oxford, United Kingdom
Established in 2017
2-10 People
Healthcare, Drug Discovery and Delivery

Founders

Stuart Hughes

Stuart Hughes

CEO

Ex: Vertex Pharmaceuticals, Eli Lilly, Cardiff University, Convergent Business Systems

Oxford, England, United Kingdom

Tom McCarthy

Tom McCarthy

Founder and Chair

Oxford, England, United Kingdom

Investment details

Total Funding
$58,000,000
Raised
$25,000,000
Round
Series B
Investors
Bristol Myers Squibb
Canaan Partners
Brandon Capital

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United Kingdom

May2024
1

Today

Bicycle raised $555M from Forbion and 6 others
UK-based Bicycle Therapeutics develops precision-guided therapeutics using 'bicycle' molecules for cancer and disease treatment.
Bicycle

Founders

Sir Gregory Winter

In News

Tech.eu
2

1 day ago

Viable raised a $3M Seed led by Martin Brailsford
London-based Viable is an Intelligent Finance platform for online and multi-channel sellers.
Viable

Founders

Henry Young,

Franklyn Martin,

Steven Haynes

In News

Silicon Canals
Tech Funding News
3

1 day ago

GreyWolf Therapeutics raised a $49.6M Series B led by ICG’s Life Sciences team
Oxfordshire-based Grey Wolf Therapeutics develops antigen modulation therapies for oncology and autoimmunity.
GreyWolf Therapeutics

Founders

Peter Joyce

In News

EU-Startups
4

2 days ago

Praktika raised a $32.5M Series A led by Blue Wire Capital
London-based Praktika delivers AI-powered language learning with personalized avatars.

Founders

Carles Reina,

Adam Turaev

In News

FinSMEs
Tech Funding News
5

3 days ago

Pheon Therapeutics raised a $120M Series B led by Research Corporation Technologies
London-based Pheon Therapeutics is an ADC specialist developing next-generation ADCs for hard-to-treat cancers.
Pheon Therapeutics

Founders

Cyrus Mozayeni

In News

FinSMEs
The pharma letter
Informazione
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.